Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

2yrs ago Private Equity privateequitywire Views: 392

Kempen Private Markets Fund invests in UK-based Channel 3 Consulting

Submitted 29/06/2021 - 9:07am

The Kempen Private Markets Fund has acquired a direct interest in UK healthcare consultancy Channel 3 Consulting (Channel 3). Channel 3 designs, implements and optimises digital transformation programmes for the health and care sector.

Established in 2009, Channel 3 helps its clients harness the power of technology to deliver better patient outcomes, improve services and operate more efficiently. Over the past decade, Channel 3 has worked with over 90 organisations across the National Health Service (NHS), private healthcare, local government, the Ministry of Defence and the wider public sector. It is currently appointed to several key NHS frameworks.
 
Kempen co-invests in the management buyout together with its long-term UK investment partner WestBridge Capital and as a group they have a majority stake in the business, with the balance owned by the Channel 3 management team.
 
Sven Smeets, Managing Director of Kempen Private Markets, comments: ‘With Channel 3 we back a highly experienced management team in the buyout of a niche, high growth digital healthcare consultancy business. In recent years, CEO John Howard and his team have proven their ability to capitalise on Channel 3’s strong fundamentals in the growing and dynamic health and care sector, which demonstrates great momentum for further digitalisation. We are delighted to be part of this journey together with our partner WestBridge Capital and we are committed to supporting management with the growth of Channel 3 in the years to come.’
 
Jorrit Willigers, Director of Kempen Private Markets, adds: ‘An example of a project that Channel 3 is focusing on is the digital transformation of the UK's NHS. The need to digitalise the NHS has been understood for many years and the challenges presented by Covid-19 have emphasized this further. Longer term, the launch of NHSX in 2019 - a collaboration between the Department of Health and Social Care, NHS England and NHS Improvement tasked with driving the digital transformation of healthcare - presents strong opportunities for Channel 3.’
 
Guy Davies, Managing Partner at WestBridge Capital, says: ‘We are pleased to report that with the support of our co-investor Kempen we have successfully closed the management buyout of Channel 3.  We are delighted that Kempen has chosen WestBridge as its UK private equity investment partner and that they are co-investing with us in Channel 3. We look forward to working with Kempen and the management team on this very exciting opportunity. We have worked together with Kempen for years on various other successful deals and we view the Kempen team as a partner in an alliance that offers room for professional, long term entrepreneurial investing.’
 

Like this article? Sign up to our free newsletter Related Topics Deals & Transactions Healthcare & Life Sciences Investments

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.